New analysis from EUROCARE 5

Nivolumab versus Everolimus in Advanced Renal Cell Carcinoma

Cabozantinib vs. everolimus in patients with advanced renal cell carcinoma: results of a randomized phase 3 trial (METEOR)

Tumor growth over time: analysis of data from the LUME-Lung 1 trial

Understanding Physician Prescribing Behavior in Second-Line Adenocarcinoma of the Lung

Genomic characterization of brain metastases and paired primary tumors reveals branched evolution and potential therapeutic targets

Efficacy and Safety Results from the Placebo-Controlled, Double-blind, Multicenter, Ph

Lu-177-Dotatate Significantly Improves Progression-Free Survival in Patients with Midgut Neuroendocrine Tumours: Results of the Phase III NETTER-1 Trial

Two-year estimate of overall survival in COMBI-v, a randomized, open-label, phase III study comparing the combination of dabrafenib + trametinib vs. vemurafenib as first-line ther

The effect of aspirin as additional treatment in patients with a gastrointestinal malignancy

Ovarian suppression using luteinizing hormone-releasing hormone agonists during chemotherapy to preserve ovarian function and fertility of breast cancer patients.

Phase I sudy of a DLL3-targeted antibody drug conjugate (ADC), rovalpituzumab tesirine, in patients with relapsed and refractory small cell lung cancer (

Social deprivation & gender affect incidence of Hodgkin lymphoma in children & young adults

Outcome of 129 children after antenatal exposure to cancer treatment: Results of a case-control study from the International Network on Cancer, Infertility and Pregnancy

The novelties of ECCO2015 and the impaired cancer treatment access in CE Europe

Tumor growth over time in patients with advanced NSCLC Treated with nintedanib plus docetaxel vs. docetaxel: Analysis of data from the LUME-Lung 1 study

Renal cell carcinoma as new target of immunotherapy: the CheckMate 025 study

Highlights in targeted therapy and immunotherapy at ECCO2015

Launch of the European Society for Paediatric Oncology strategic cancer plan for children and adolescents

Reflects on the findings and suggestions of the radiotherapy commission

Expanding global access to radiotherapy: myths and facts

The significance of NETTER-1 trial in the world-wide approval of peptide receptor radionuclide therapy for the treatment of NETs

Role of immunotherapy in renal cell cancer

Treatment options of neuroendocrine tumors with focus on the NETTER-1 Trial

Highlights of ECCO2015 congress as well as the future role of ESMO and ECCO

Use of aspirin after diagnosis improves survival in many gastrointestinal cancer types according to retrospective, registry data

Shares her insight on the importance of modern cancer research for humanity, and talks about the most significant developments in cancer science

The role of immunotherapy and checkpoint inhibitors in the treatment of genitourinary malignancies: new results presented at ECCO2015

Evaluation of ovarian suppression with LHRH agonists during chemotherapy as an option to preserve ovarian function and fertility in breast cancer patients

Should cancer diagnosis during pregnancy lead to treatment delay or pregnancy termination?